Viking Therapeutics, Inc. (NASDAQ:VKTX) faced a 15.08% drop in share price last week due to concerns about US government drug price negotiations. Despite a slight gain on Friday, VKTX ranked 3rd on the list of worst performers.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing